卡马西平制剂的研究进展

被引：22

作者：

陈宝

郑思嘉

吴传斌

机构：

[1] 中山大学药学院

来源：

国际药学研究杂志 | 2008年 / 01期

关键词：

卡马西平; 药用制剂; 投药,口服; 生物利用度;

D O I：

10.13220/j.cnki.jipr.2008.01.035

中图分类号：

R971 [神经系统药物];

学科分类号：

100115 [医学神经生物学];

摘要：

通过查阅大量的文献,对近年来卡马西平在制剂方面的研究进展进行整理分析,阐述卡马西平制剂在各种给药途径特别是口服给药的新进展,提出今后的研究方向重点是提高卡马西平口服制剂的生物利用度和改善口服制剂的稳定性。

引用

页码：46 / 49+58 +58

页数：5

共 16 条

[1]

Improved solubilization of carbamazepine and structural transitions in nonionic microemulsions upon aqueous phase dilution [J].

Kogan, Anna ;

Aserin, Abraham ;

Garti, Nissim .

JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2007, 315 (02) :637-647

[2]

Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process.[J].Regina G. Kelmann;Gislaine Kuminek;Helder F. Teixeira;Letícia S. Koester.International Journal of Pharmaceutics.2007, 1

[3]

Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).[J].Yousef Javadzadeh;Baharak Jafari-Navimipour;Ali Nokhodchi.International Journal of Pharmaceutics.2007, 1

[4]

In vitro performance of carbamazepine loaded to various molecular weights of poly(D,L-lactide-co-glycolide) [J].

Barakat, NS ;

Radwan, MA .

DRUG DELIVERY, 2006, 13 (01) :9-18

[5]

Thermally reversible in situ gelling carbamazepine liquid suppository [J].

El-Kamel, A ;

El-Khatib, M .

DRUG DELIVERY, 2006, 13 (02) :143-148

[6]

Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model [J].

Carino, SR ;

Sperry, DC ;

Hawley, M .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (01) :116-125

[7]

In vitro–in vivo evaluation of supercritical processed solid dispersions: Permeability and viability assessment in Caco‐2 cells.[J].SundeepSethia;EmilioSquillante.J. Pharm. Sci..2004, 12

[8]

Carbamazepine/βCD/HPMC Solid Dispersions. I. Influence of the Spray-Drying Process and βCD/HPMC on the Drug Dissolution Profile.[J].Letícia S. Koester;Paulo Mayorga;Valquiria L. Bassani.Drug Development and Industrial Pharmacy.2003, 2

[9]

Carbamazepine/&bgr;CD/HPMC Solid Dispersions. II. Physical Characterization.[J].L. S. Koester;P. Mayorga;V. P. Pereira;C. L. Petzhold;V. L. Bassani.Drug Development and Industrial Pharmacy.2003, 2

[10]

Formulation of intravenous Carbamazepine emulsions by SolEmuls ? technology.[J].A. Akkar;R.H. Müller.European Journal of Pharmaceutics and Biopharmaceutics.2003, 3

← 1 2 →